Form 4 for PGEN PRECIGEN, INC.
Accepted 2022-01-04 00:00:00 ET · period of report 2022-01-02 · accession 0000950103-22-000138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-04 | 2022-01-02 | PGEN | Sabzevari Helen | Pres, CEO, Dir | M - OptEx | — | +9,765 | 727.3K | +1% | — |
| D | 2022-01-04 | 2022-01-03 | PGEN | Sabzevari Helen | Pres, CEO, Dir | S - Sale+OE | $3.67 | -3,848 | 723.4K | -0.5% | -$14.1K |
| D | 2022-01-04 | 2022-01-02 | PGEN | Sabzevari Helen | Pres, CEO, Dir | M - OptEx | $0.00 | -9,765 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-02 | M | A | 9,765 | — | 727,291 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| 2 | Common | Common Stock | 2022-01-03 | S | D | 3,848 | $3.67 | 723,443 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-01-02 | M | D | 9,765 | $0.00 | 0 | D | — · — to — | 9,765 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. (F3) The RSUs were granted on January 2, 2018 and have vested in full. |